Article
Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant.
International journal of radiation oncology, biology, physics - 1 May 2012
Schirmer Markus Anton, Mergler Caroline Patricia Nadine, Rave-Fränk Margret, Herrmann Markus Karl, Hennies Steffen, Gaedcke Jochen, Conradi Lena-Christin, Jo Peter, Beissbarth Tim, Hess Clemens Friedrich, Becker Heinz, Ghadimi Michael, Brockmöller Jürgen, Christiansen Hans, Wolff Hendrik Andreas
Abstract excerpt
PURPOSE: Transforming growth factor-beta1 is related to adverse events in radiochemotherapy. We investigated TGFB1 genetic variability in relation to quality of life-impairing acute organ toxicity (QAOT) of neoadjuvant radiochemotherapy under clinical trial conditions. METHODS AND MATERIALS: Two independent patient cohorts (n = 88 and n = 75) diagnosed with International Union Against Cancer stage II/III rectal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
